Group 2 Innate Lymphoid Cells Support Hematopoietic Recovery Under Stress Conditions
Overview
General Medicine
Authors
Affiliations
The cell-cycle status of hematopoietic stem and progenitor cells (HSPCs) becomes activated following chemotherapy-induced stress, promoting bone marrow (BM) regeneration; however, the underlying molecular mechanism remains elusive. Here we show that BM-resident group 2 innate lymphoid cells (ILC2s) support the recovery of HSPCs from 5-fluorouracil (5-FU)-induced stress by secreting granulocyte-macrophage colony-stimulating factor (GM-CSF). Mechanistically, IL-33 released from chemo-sensitive B cell progenitors activates MyD88-mediated secretion of GM-CSF in ILC2, suggesting the existence of a B cell-ILC2 axis for maintaining hematopoietic homeostasis. GM-CSF knockout mice treated with 5-FU showed severe loss of myeloid lineage cells, causing lethality, which was rescued by transferring BM ILC2s from wild-type mice. Further, the adoptive transfer of ILC2s to 5-FU-treated mice accelerates hematopoietic recovery, while the reduction of ILC2s results in the opposite effect. Thus, ILC2s may function by "sensing" the damaged BM spaces and subsequently support hematopoietic recovery under stress conditions.
Optical histopathology based on the nonlabeling analysis with multiphoton excitation imaging.
Matsui T Pathol Int. 2024; 75(1):1-10.
PMID: 39660963 PMC: 11760634. DOI: 10.1111/pin.13498.
Mei Z, Khalil M, Guo Y, Li D, Banerjee A, Taheri M Sci Transl Med. 2024; 16(761):eadl4222.
PMID: 39167663 PMC: 11636577. DOI: 10.1126/scitranslmed.adl4222.
Abbasizadeh N, Burns C, Verrinder R, Ghazali F, Seyedhassantehrani N, Spencer J Front Cell Dev Biol. 2024; 12:1441381.
PMID: 39139448 PMC: 11319712. DOI: 10.3389/fcell.2024.1441381.
Stage-specific GATA3 induction promotes ILC2 development after lineage commitment.
Furuya H, Toda Y, Iwata A, Kanai M, Kato K, Kumagai T Nat Commun. 2024; 15(1):5610.
PMID: 38969652 PMC: 11226602. DOI: 10.1038/s41467-024-49881-y.
Type 2 immunity in the brain and brain borders.
Mamuladze T, Kipnis J Cell Mol Immunol. 2023; 20(11):1290-1299.
PMID: 37429945 PMC: 10616183. DOI: 10.1038/s41423-023-01043-8.